Epizyme

Epizyme has been on a mission to re-invent therapy for serious diseases including cancer through the use of targeted epigenetic medicines. Since 2011, Epizyme has raised the bar for patient and physician care by discovering five novel epigenetic therapies. Through their advanced scientific capabilities, Epizyme has and continues to expand their platform into new target classes in epigenetics, which are likely to play a huge role in disease biology in the future.